Press Releases

Date	Title and Summary
Toggle SummaryJune 30, 2014	Capnia Appoints William G. Harris to its Board of Directors REDWOOD CITY, Calif., June 30, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices to detect analytes in exhaled breath, today announced the appointment of William G. Harris to its Board of Directors. Mr. Harris brings to Capnia more than 20 years of financial
Toggle SummaryJuly 7, 2014	Capnia Appoints Gina Phelps as Vice President of Sales REDWOOD CITY, Calif., July 7, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices that detect analytes in exhaled breath, today announced the appointment of Gina Phelps as Vice President of Sales, a newly created position. Ms.
Toggle SummaryJuly 9, 2014	Capnia Appoints David O'Toole as Chief Financial Officer REDWOOD CITY, Calif., July 9, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices that detect analytes in exhaled breath, today announced the appointment of David O'Toole as Chief Financial Officer, a significant expansion of the executive management.
Toggle SummaryNovember 13, 2014	Capnia, Inc. Announces Pricing of Initial Public Offering REDWOOD CITY, Calif. , Nov. 13, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN) announced today the pricing of its initial public offering of 1,650,000 units, each unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to
Toggle SummaryNovember 18, 2014	Capnia, Inc. Announces Closing of Initial Public Offering and Partial Exercise of Over-Allotment Option REDWOOD CITY, Calif. , Nov. 18, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN) announced today the closing of its initial public offering of 1,650,000 units, each unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to
Toggle SummaryDecember 8, 2014	Capnia Presents CoSense® Data at the 2014 American Society of Hematology Annual Meeting REDWOOD CITY, Calif. , Dec. 8, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of medical diagnostics based on its proprietary Sensalyze™ technology for precision metering of gas flow, today announced a poster presentation at the 2014 American Society of Hematology
Toggle SummaryDecember 18, 2014	Capnia Reports Third Quarter 2014 Financial Results REDWOOD CITY, Calif. , Dec. 18, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of medical diagnostics based on its proprietary Sensalyze™ Technology Platform for precision metering of gas flow, today announced financial results for the third quarter and nine months
Toggle SummaryJanuary 5, 2015	Capnia to Present at OneMedForum 2015 REDWOOD CITY, Calif. , Jan. 5, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that Anish Bhatnagar , M.D., Chief Executive Officer, will
Toggle SummaryJanuary 6, 2015	Capnia and Clinvest® Partner to Develop Cluster Headache Therapeutic REDWOOD CITY, Calif. , Jan. 6, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, and Clinvest®, a research organization dedicated to the advancement of
Toggle SummaryJanuary 8, 2015	Capnia Applies for Orphan Drug Designation in the U.S. for the Treatment of Trigeminal Neuralgia REDWOOD CITY, Calif. , Jan. 8, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that it has submitted an application to the U.S.

Print Page RSS Feeds Email Alerts IR Contacts